CLINICAL_TRIALS
trial_result
· 2022-11-03
Clinical Trial Update: Efficacy and Safety of Oral BT-11 in Ulcerative Colitis [Phase 2]
Summary
Phase 2 trial results for oral BT-11 in ulcerative colitis have been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NImmune Biopharma | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2022-11-03